Company Filing History:
Years Active: 1998-2000
Title: Michael Dorschug: Innovator in Recombinant Proteins
Introduction
Michael Dorschug is a notable inventor based in Heiligenhaus, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins. With a total of 2 patents, Dorschug's work has had a meaningful impact on medical and pharmaceutical applications.
Latest Patents
Dorschug's latest patents include innovative advancements in the use of hIL-4 mutant proteins. These proteins are utilized as antagonists or partial agonists of human functions. Additionally, he has developed a process for preparing recombinant aprotinin and its variants. This process ensures that the recombinant aprotinin and its variants are present as homogeneously processed, secreted proteins, which is crucial for their effectiveness in therapeutic applications.
Career Highlights
Throughout his career, Dorschug has worked with Bayer Aktiengesellschaft, a leading global pharmaceutical company. His experience in such a prestigious organization has allowed him to refine his skills and contribute to groundbreaking research in the field of biotechnology.
Collaborations
Dorschug has collaborated with esteemed colleagues, including Jurgen Beunink and Heiner Apeler. These partnerships have fostered a collaborative environment that has led to innovative solutions in the development of recombinant proteins.
Conclusion
Michael Dorschug's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and therapeutic applications.